
Francis Ball
01 May 2026
Viral Clearance Strategies for Biopharmaceuticals and Cell & Gene Therapies
7-hour
Risk and impact of viral contamination in biopharmaceutical manufacturing, Regulatory landscape, Examine the requirements of specific products, Risk prevention and Viral clearance studies
Mylène Talabardon and Hervé Broly
FB
Issued to
Francis Ball
Want to report a typo or a mistake?
Credential Verification
Issue date: May 1, 2026
ID: 6e7eb87f-1b55-4305-9bee-b1fda8627922
Type
Course
Level
Professional
Price
Paid
Earning Criteria
Participation
Attended the course held by Educo Life Sciences.
Watching
Or watched the recorded materials for the course held by Educo.